All
FDA Approves Reblozyl for Anemia in Adults with Lower-Risk Myelodysplastic Syndromes
April 4th 2020The Food and Drug Administration approved the first and only erythroid maturation agent to treat patients with MDS who require red blood cell transfusions and have failed an erythropoiesis stimulating agent.
Friday Frontline: Cancer Updates, Research and Education on April 3, 2020
April 3rd 2020From an investigational cancer therapy being studied as a treatment for COVID-19 to the NBA and NHL helping to raise over $500,000 for prostate cancer research, here’s what’s making headlines in the cancer space this week.
4 Things Patients with Cancer Might Have Missed Regarding COVID-19
April 2nd 2020As the novel coronavirus outbreak begins impacting many facets of cancer care in the United States, it’s easy to have possibly missed some of the news surrounding COVID-19 and cancer. Here are four things that our readers may have missed.
How COVID-19 is Impacting Patients with Chronic Lymphocytic Leukemia
April 1st 2020The COVID-19 pandemic's impact is being felt all throughout the cancer community, and experts from the CLL Society hosted a webinar to discuss the specific impacts of the pandemic on patients with chronic lymphocytic leukemia.
Friday Frontline: Cancer Updates, Research and Education on March 27, 2020
March 27th 2020From patients having to reschedule treatment appointments due to the novel coronavirus (COVID-19) outbreak, to clinical trials being put on hold, here’s everything you need to know about how the COVID-19 pandemic is impacting patients with cancer.
How Patients with Cancer, and Survivors, Can Manage Stress Through COVID-19 Uncertainty
March 27th 2020Dr. Shelley Johns, a researcher with the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and Regenstrief Institute, offers advice on how survivors and patients with cancer can recognize and manage the stress they may be experiencing as a result of the COVID-19 pandemic.
Screening and Treatment Can Significantly Reduce Cancer Deaths Over the Next 10 Years, Expert Says
March 27th 2020Estimates indicate that cancer will become the number one leading cause of death in the United States over the next five to 10 years. But, as one expert argued in a policy roundtable, there are ways to significantly decrease that rate.